stars 1 stars 2 stars 3

Third Pole, Inc. is a US-based company developing next generation life-saving cardiopulmonary therapies. We are building on our team’s legacy in inhaled nitric oxide (NO), the current standard of care, to develop next generation life-saving heart and lung therapies. Our first product is being designed to be a simple, convenient, economical, and lightweight device capable of generating nitric oxide from air on-demand and on-site which potentially eliminates the need for large compressed gas cylinders. We believe our novel approach of creating NO on demand has the promise to create new markets by enabling the worldwide use of inhaled NO in settings outside of acute care.

Third Pole Therapeutics Questions

The Third Pole Therapeutics annual revenue was $10.1 million in 2026.

Bill Athenson is the CEO of Third Pole Therapeutics.

25 people are employed at Third Pole Therapeutics.

Third Pole Therapeutics is based in Waltham, Massachusetts.

The NAICS codes for Third Pole Therapeutics are [5417, 541, 54, 54171, 541714].

The SIC codes for Third Pole Therapeutics are [87, 873].

Top Third Pole Therapeutics Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users